Oxidative DNA Damage in Barrett Mucosa: Correlation with Telomeric Dysfunction and p53 Mutation

被引:18
|
作者
Cardin, Romilda [1 ]
Piciocchi, Marika [1 ]
Tieppo, Chiara [1 ]
Maddalo, Gemma [2 ]
Zaninotto, Giovanni [1 ]
Mescoli, Claudia [3 ]
Rugge, Massimo [3 ]
Farinati, Fabio [1 ]
机构
[1] Univ Padua, Gastroenterol Sect, Dept Surg Oncol & Gastroenterol, Padua, Italy
[2] IRCCS, IOV, Venetian Inst Oncol, Padua, Italy
[3] Univ Padua, Dept Med, Pathol & Cytopathol Unit, Padua, Italy
关键词
GASTROESOPHAGEAL-REFLUX; CHRONIC INFLAMMATION; HELICOBACTER-PYLORI; COLORECTAL-CANCER; GASTRIC-CANCER; RISK-FACTORS; ESOPHAGUS; STRESS; REPAIR; GENE;
D O I
10.1245/s10434-013-3043-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Barrett esophagus develops in a scenario of chronic inflammation, linked to free radical formation and oxidative DNA damage. Eight-hydroxydeoxyguanosine, the main oxidative DNA adduct, is partially repaired by a glycosylase (OGG1) whose polymorphism is associated to a reduced repair capacity. Telomeres are particularly prone to oxidative damage, which leads to shortening and cell senescence, while elongation, by telomerase activity, is linked to cell immortalization and cancer. Limited data are available on this point with respect to Barrett esophagus. This study aimed to evaluate the link among 8-hydroxydeoxyguanosine, OGG1 polymorphism, telomerase activity, telomere length, and p53 mutation in Barrett progression. Methods. Forty consecutive patients with short- and long-segment Barrett esophagus and 20 controls with gastroesophageal reflux disease without Barrett esophagus were recruited. Analysis of biopsy samples was undertaken to study 8-hydroxydeoxyguanosine levels, OGG1 polymorphism, telomerase activity, and telomere length. Serum samples were obtained for p53 mutation. Results. Controls had significantly lower levels of 8-hydroxydeoxyguanosine and telomerase activity, with normal telomere length and no p53 mutation. In short- segment Barrett esophagus, 8-hydroxydeoxyguanosine levels were higher and telomeres underwent significant shortening, with stimulation of telomerase activity but no p53 mutations. In long-segment Barrett esophagus, 8-hydroxydeoxyguanosine reached maximal levels, with telomere elongation, and 42 % of the patients showed p53 mutation. Conclusions. In Barrett patients, with disease progression, oxidative DNA damage accumulates, causing telomere instability, telomerase activation, and, in a late phase, mutations in the p53 gene, thus abrogating its activity as the checkpoint of proliferation and apoptosis, and facilitating progression to cancer.
引用
收藏
页码:S583 / S589
页数:7
相关论文
共 50 条
  • [31] How P53 is activated following DNA damage
    Frankish, H
    LANCET, 2001, 357 (9271): : 1857 - 1857
  • [32] Regulation of the DNA Damage Response by p53 Cofactors
    Zhang, Xiao-Peng
    Liu, Feng
    Wang, Wei
    BIOPHYSICAL JOURNAL, 2012, 102 (10) : 2251 - 2260
  • [33] DNA-DAMAGE, P53 AND ANTICANCER THERAPIES
    MILNER, J
    NATURE MEDICINE, 1995, 1 (09) : 879 - 880
  • [34] ARSENITE INTERFERES WITH P53 RESPONSE TO DNA DAMAGE
    Zhang, Jiang Lin
    Huang, Ye Lin
    Dibble, Christian
    McHenry, Kevin
    Kim, Mihee
    Yuan, Zhi Min
    CELL BIOLOGY INTERNATIONAL, 2008, 32 (03) : S39 - S39
  • [35] The role of DNA damage responses in p53 biology
    Daniel Speidel
    Archives of Toxicology, 2015, 89 : 501 - 517
  • [36] p53 in the DNA-Damage-Repair Process
    Williams, Ashley B.
    Schumacher, Bjoern
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2016, 6 (05):
  • [37] p53 partners with RNA in the DNA damage response
    Huarte, Maite
    NATURE GENETICS, 2016, 48 (11) : 1298 - 1299
  • [38] p53 partners with RNA in the DNA damage response
    Maite Huarte
    Nature Genetics, 2016, 48 : 1298 - 1299
  • [39] DNA damage, p53, apoptosis and vascular disease
    Mercer, John
    Mahmoudi, Melli
    Bennett, Martin
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2007, 621 (1-2) : 75 - 86
  • [40] DNA damage responses and p53 in the aging process
    Ou, Hui-Ling
    Schumacher, Bjoe
    BLOOD, 2018, 131 (05) : 488 - 495